CARDIFF ONCOLOGY INC shareholders Q2 2023

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 54 filers reported holding CARDIFF ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

CARDIFF ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 296,677$4360.04%
ELKHORN PARTNERS LIMITED PARTNERSHIP 47,000$690.04%
DENVER WEALTH MANAGEMENT, INC. 18,235$26,8050.02%
FinDec Wealth Services, Inc. 16,000$23,5200.02%
Atom Investors LP 18,298$26,8980.01%
Laurion Capital Management LP 722,100$1,061,4870.01%
Tortoise Investment Management, LLC 15,000$22,0500.00%
Callan Capital, LLC 13,587$19,9730.00%
America First Investment Advisors, LLC 4,000$5,8800.00%
Renaissance Technologies 311,290$4580.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 97,053$142,6680.00%
BLAIR WILLIAM & CO/IL 130,500$191,8350.00%
Assenagon Asset Management S.A. 142,428$209,3690.00%
TWO SIGMA ADVISERS, LP 172,800$254,0160.00%
Gladstone Institutional Advisory LLC 14,000$20,5800.00%
Bank of New York Mellon Corp 14,350$21,0940.00%
Citadel Advisors 10,100$14,8470.00%
Citadel Advisors 86,123$126,6010.00%
CAPSTONE INVESTMENT ADVISORS, LLC 51,190$75,2490.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 94,504$138,9210.00%
External links

This page lists CARDIFF ONCOLOGY INC's shareholders in Q2 2023. To view CARDIFF ONCOLOGY INC's shareholder history, click here.